CERC's Kevin Schulman , is urging White House analysts to investigate the power of intermediaries in drug pricing. “The intermediaries are driving people out of the market," the NY Times reports. #pharmaceuticals #PBMs nytimes.com/2023/05/17/hea…

5.7 years: the median time it takes for Medicare coverage of novel medical devices after FDA authorization. Join CERC's @Kevin_Schulman and leaders from Stanford Biodesign as they discuss their findings published in @JAMA. #medtech #stanfordmed

In their new Forefront article, Kevin Schulman, Wasan Kumar, + Eli Adashi from Stanford Medicine discuss how each generic entry drives down the cost of generic medications + how this pricing model helped to create strains in the generic drug market. bit.ly/45XjU4a

New Casey Christman study shows recalls of generic metformin ER were effective in lowering levels of the carcinogen MDNA while having little impact on price or availability of the drug.tinyurl.com/ybuyx857 #genericdrugs #drugrecall Kevin Schulman

AI Alone Will Not Reduce the Administrative Burden of Health Care write CERC's Kevin Schulman, StanfordHealthPolicy's Perry Nielsen Jr. & @SUBidesign's Kavita Patel M.D. in this JAMA Network Viewpoint. jamanetwork.com/journals/jama/…

AI Alone Will Not Reduce the Administrative Burden of Health Care write CERC's Kevin Schulman, StanfordHealthPolicy's Perry Nielsen Jr. & Stanford Biodesign's Kavita Patel M.D. in this@JAMANetwork Viewpoint. t.ly/Hg-rb

Congratulations to CERC's Kevin Schulman and Barak Richman on their latest paper revealing a unique approach to reducing healthcare administrative costs: t.ly/wQpdk

Lancet Psychiatry Commission: Transforming Mental Health Implementation Research. “So much of what we know works doesn’t work in practice because it’s not implemented or scaled well,” says SHP's Sara Singer, a member of the Lancet commission. ⚕️🧠 healthpolicy.fsi.stanford.edu/news/transform…

Congratulations to Stanford's Partnership for AI-Assisted Care! At an event at White House, @PAC’s Ehsan Adeli accepted the award of a groundbreaking U.S. National Science Foundation grant for its research applying computer vision to improving patient care and outcomes.

There’s little incentive for large drug purchasers like pharmacies and hospitals to choose suppliers based on quality" - CERC's Kevin Schulman, quoted in Bloomberg. That leads to dangerous contaminants -and product recalls.#genericdrugs #CVS recalls.tinyurl.com/mwndma2z

From HPMI editor-in-chief Kevin Schulman of CERC, this month’s special issue of HMPI features research and analyses on private equity's role in shaping care delivery, patient health outcomes, costs, and the health care industry landscape. #PrivateEquity

Guest-edited by Stanford CERC senior scholar Nicholas Stine, this special issue of NEJM Catalyst features case studies and insights from "unique bright spots of collaboration." @DrNickStine #StanfordMed

CERC's Kevin Schulman: FDA has massive backlog of factory inspections as staffers leave for private sector jobs apnews.com/article/fda-in… Stanford Medicine #genericdrugs

A recent paper by #StanDOM's Dina Sheira & Kevin Schulman unveils how Pharmacy Benefit Managers (PBMs) contribute to rising drug prices. Check out their findings on market control & lack of transparency in JAHA. 👇 bit.ly/3BZj2CV

It seems private companies look at how their health #insurance plans impact their budgets rather than how they benefit the health and well-being of their employees, according to a new Stanford study by SHP's Sara Singer & Stanford Graduate School of Business's Jeffrey Pfeffer.

A study shows that doctors using a chatbot outperform those who only accessed internet search and medical references when making nuanced medical decisions. stan.md/4goZ2Yo

Perspective by Alice T. Chen, MD (Alice Chen MD), and Vivek Murthy, MD, MBA: The Power of Physicians in Dangerous Times nej.md/42ThILc #HealthPolicy #MedEd

The amazing 𝗣𝗲𝘁𝗲𝗿 𝗣𝗶𝗼𝘁 keynotes #RosenkranzGlobal Health Policy Research Symposium on May 20. He joins other global health experts from around the world to present their work. Join us; details & registration ⬇️⬇️ bit.ly/3OtRGHm

NBC report: Joint study from CERC, PatientRightsAdvocate.org and GW Law revealed Colorado nonprofit uchealth used intermediaries to sue thousands of patients for medical bills while offering patients no easy access to prices. shorturl.at/uAJHk

According to a study led by #StanDOM's Kevin Schulman, some generic #ADHD medications may not be living up to their brand-name counterparts. bit.ly/40HBgBL